Recently Cortado announced our investment in Edmond based Watkins Conti Products. We invest in ambitious companies tackling big problems and in teams with the “right stuff” to make it happen. Here we discuss our thinking behind our investments and the trends that drive our conviction. Thank you to Patrick Sweeney, Cortado Research Fellow and Harvard Business School Research Associate, for his considerable help bringing together the research and narrative. Today we also welcome the insights of celebrity guest Dr. Donnica Moore.
Watkins Conti is a healthcare company that develops and commercializes products to address women’s health issues. The company has developed its first product, the Yōni.Fit, to address both the causes and the symptoms of stress urinary incontinence (SUI) or involuntary urine leakage in women. The company has plans for expansion beyond the Yōni.Fit to other women’s health products including at-home STD testing and yeast monitoring. The Yōni.Fit is a nonsurgical, intravaginal device made of medical grade silicone for women suffering from SUI. Pre-clinical testing has been going exceptionally well, far exceeding requirements to commercialize the product. The market for biotech addressing women’s health issues is booming, and CEO Allison Conti is an experienced business and thought leader. As a thought leader, Allison is removing the taboo and enabling women throughout the country to speak out. Allison is regularly asked to speak and share her journey to becoming her own boss and succeeding in the world of technology innovation and venture capital — an area too often dominated by men